Browsing by Author "Karadurmuş N"

Now showing items 1-3 of 3

Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study

Bilir C; Yıldız İ; Bilici A; Ucar M; Berk V; Yıldız Y; Yazıcı O; İmamoğlu Gİ; Karadurmuş N; Pilancı KN; Arpacı E; Tanrıverdi Ö; Karcı E; Temiz S; Nayır E; Oktay E; Dal P; Petekkaya İ; Varım C; Cinemre H. (2017)
Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

Oktay E; Levent M; Gelincik H; Aktaş G; Yumuk F; Koral L; Arpacı E; Keser M; Alkan A; Karci E; Karadurmuş N; Degirmencioglu S; Turan M; Uyeturk U; Cabuk D; Avci N; Toprak O; Ergen A; Urvay S; Bayman E; Petekkaya E; Nayir E; Paydaş S; Yavuzsen T; Senler FC; Yaren A; Barutca S; Şahinler İ; Ozyilkan O; Tanriverdi O. (2020)
Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy

Yildiz I; Bilici A; Karadurmuş N; Ozer L; Tural D; Kaplan MA; Akman T; Bayoglu IV; Uysal M; Yildiz Y; Tanriverdi Ö; Yazici O; Sürmeli Z; Serdar Turhal N; Bavbek S; Selçukbiricik F; Koca D; Basaran M. (2018)